Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Craig C. Hopkinson Insider Profile
4 Followers
Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes, holds 47.58K shares in Alkermes (Ticker: ALKS), holds 10.49K shares in Albireo Pharma (Ticker: ALBO).
Craig C. Hopkinson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Craig C. Hopkinson's holdings
Insider Roles
EVP R&D, Chief Medical Officer
Roles that Craig C. Hopkinson holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Craig C. Hopkinson
Craig C. Hopkinson's Trading History
Alkermes
Dec 09, 2024
EVP R&D, Chief Medical Officer
Uninformative Buy
1.11M
$1.41M
Albireo Pharma
Dec 05, 2022
―
Uninformative Buy
―
$463.35K
List of latest transactions for each holding click on a transaction to see Craig C. Hopkinson's performance on stock
You May Also Like
Craig C. Hopkinson insider profile FAQ
What is the percentage of profitable transactions made by Craig C. Hopkinson?
The percentage of profitable transactions made by Craig C. Hopkinson is ―.
What is the average return per transaction made by Craig C. Hopkinson?
The average return per transaction made by Craig C. Hopkinson is ―.
What stocks does Craig C. Hopkinson hold?
Craig C. Hopkinson holds: ALKS, ALBO stocks.
What was Craig C. Hopkinson’s latest transaction?
Craig C. Hopkinson latest transaction was an Uninformative Buy of $1.11M.
What was Craig C. Hopkinson's most profitable transaction?
Craig C. Hopkinson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Craig C. Hopkinson's role in Alkermes?
Craig C. Hopkinson's role in Alkermes is EVP R&D, Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.